Search Login Register

Endotoxemia Summary

Description: A condition characterized by the presence of ENDOTOXINS in the blood. On lysis, the outer cell wall of gram-negative bacteria enters the systemic circulation and initiates a pathophysiologic cascade of pro-inflammatory mediators.

Also Known As: Endotoxemias

Networked: 3925 relevant articles (277 outcomes, 593 trials/studies) for this Disease

Key Drugs and Agents for Endotoxemia

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor) : 21 outcomes 38 studies in 386 results : IBA
  2. Cytokines : 10 outcomes 30 studies in 226 results : IBA
  3. HMGB1 Protein (HMG1) : 10 outcomes 4 studies in 55 results : IBA
  4. Interleukin-10 (Interleukin 10) : 9 outcomes 10 studies in 91 results : IBA
  5. Antibodies : 8 outcomes 1 study in 30 results : IBA
  6. Nitric Oxide (Nitrogen Monoxide) : 6 outcomes 21 studies in 244 results : FDA 1
  7. Interleukin-6 (Interleukin 6) : 6 outcomes 15 studies in 155 results : IBA
  8. Polymyxin B (Aerosporin) : 6 outcomes 5 studies in 33 results : FDA 90 Generic
  9. Oxygen : 5 outcomes 12 studies in 108 results : IBA
  10. Glutamine (L-Glutamine) : 5 outcomes 11 studies in 58 results : FDA 1
Show All >>

Diseases Related to Endotoxemia

  1. Sepsis (Septicemia)
  2. Inflammation
  3. Septic Shock (Toxic Shock Syndrome)
  4. Lung Injury
  5. Shock
Show All >>

Key Therapies for Endotoxemia

Efficacy Chart >>
  1. Resuscitation : 5 outcomes 12 studies in 50 results
  2. Ligation : 4 outcomes 7 studies in 64 results
  3. Hemoperfusion : 2 outcomes 5 studies in 21 results
  4. Hepatectomy : 1 outcome 5 studies in 29 results
  5. Enteral Nutrition (Feeding, Tube) : 1 outcome 3 studies in 10 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.